Analysis of Bone Metabolism in Children with Cystic Fibrosis


One of the most important CF-related conditions is the bone disease, which is nowadays acknowledged as a significant clinical complication of CF. Imbalance between bone formation and degradation in cystic fibrosis (CF) has become an important issue for developing osteopenia. The aim of the study was to assess bone formation and resorption process with bone markers in children with cystic fibrosis (CF). Materials and methods: The study included 35 clinically stable children with CF who regularly attended the Cystic fibrosis center at the University Pediatric Clinic in Skopje, R. Macedonia. The control group was presented with 21 healthy children at the same age. Serum osteocalcin (OC), β cross laps, 25OHD and PTH were determined by ELISA assays in the CF group (mean age 8.25±SD1.9 y.) and in age-match controls (7.5±1.9 y.). Results: Vitamin D in the CF group was (23.83±10.9 ng/ml versus 25.6±11.53 in the control group, p=0.57), OC (70.88±34.24 ng/ml v.100.02±47.98, p=0.01) βcrosslaps (1.35±0.72 ng/ml v.1.54±0.73, p=0.37) and PTH (37.39±25.5 pg/ml v. 36.76±25.73, p=0.92). In the study, we did not find a significant difference for 25OHD between CF and healthy controls. OC in children with CF correlates significantly with the control and indicates a decreased formation rate whereas resorption rate is normal. Conclusion: Our results suggest that bone turnover in CF is impaired in childhood. Serum markers for bone formation can be used for predicting osteopenia in children with CF.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Buzzetti R, Salvatore D, Baldo E, et al. An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis. J Cyst Fibros 2009; 8: 229–37

  • 2. Kanis JA. Osteoporosis, revised edition, 1997, Blackwell Healthcare

  • 3. Cashman KD, Seamans K. Bone health, genetics, and personalized nutrition. Genes Nutr. 2007; 2: 47-51

  • 4. Davies JH, Evans AJ, Gregory JW. Bone mass acquisition in healthy children. Arch Dis Child 2005; 90: 373-378.

  • 5. Sermet-Gaudelus I, Souberbielle JC, Ruiz JC, et al. Low bone mineral density in young children with cystic fibrosis. Am J Respir Crit Care Med 2007; 175: 951–7.

  • 6. Grey V, Atkinson S, Drury D, et al. Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers. Pediatrics 2008; 122: 1014–20.

  • 7. Bianchi ML, Romano G, Saraifoger S, et al. BMD and body composition in children and young patients affected by cystic fibrosis. J Bone Miner Res 2006; 21: 388–96.

  • 8. Paccou J, Zeboulon N, Combescure C, et al. The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis. Calcif Tissue Int 2010; 86: 1–7.

  • 9. Mortensen LA, Chan GM, and all. Bone mineral status in prebubertal children with cystic fibrosis. The Journal of Pediatrics, Volume 136, Number 5

  • 10. Aris RM, Merkel PA, Bachrach LK, et al. Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab 2005; 90: 1888–96. J. Robertson and K. MacDonald, “Prevalence of bone loss in a population with cystic fibrosis,” British Journal of Nursing, vol. 19, no. 10, pp. 636–639, 2010.

  • 11. Baroncelli GI, Luca F and all. Bone demineralization in cystic fibrosis: evidence of imbalance between bone formation and degradation. Pediatric Research; Vol.41, No. 3, 1997

  • 12. G. S. Bhudhikanok, M. C. Wang, R. Marcus, A. Harkins, R.B. Moss, and L. K. Bachrach, “Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study”, Journal of Pediatrics, vol. 133, no. 1, pp. 18–27, 1998.

  • 13. Shead EF, Haworth CS, Gunn E, and all. Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis. Amer. Journal of respiratory and critical care medicine, Vol. 174, 2006.

  • 14. Mora S, Pitukcheewanont P, and all. Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development. Journal of bone and mineral research; Volume 14, Number 10, 1999.

  • 15. Schulze KJ, O’Brien K, and all. Efficiency of calcium absorption is not compromised in clinically stable prepubertal and pubertal girls with cystic fibrosis. Am J Clin Nutr 2003; 78: 110-6.

  • 16. Stephenson A, Jamal S, Dowdell T, et al. Prevalence of vertebral fractures in adults with cystic fibrosis and their relationship to bone mineral density. Chest 2006; 130: 539–44.

  • 17. Elkin SL, Fairney A, Burnett S, et al. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int 2001; 12: 366–72.

  • 18. Aris RM, Renner JB, Winders AD, et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 1998; 128: 186–93.

  • 19. Rovner AJ, Stallings VA, Schall JI, et al. Vita-min D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. Am J Clin Nutr 2007; 86: 1694–9.

  • 20. Buntain HM, Greer RM, Schluter PJ, et al. Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax 2004; 59: 149–55.


Journal + Issues